This is an online portal with information on donations that were announced publicly (or have been shared with permission) that were of interest to Vipul Naik. The git repository with the code for this portal, as well as all the underlying data, is available on GitHub. All payment amounts are in current United States dollars (USD). The repository of donations is being seeded with an initial collation by Issa Rice as well as continued contributions from him (see his commits and the contract work page listing all financially compensated contributions to the site) but all responsibility for errors and inaccuracies belongs to Vipul Naik. Current data is preliminary and has not been completely vetted and normalized; if sharing a link to this site or any page on this site, please include the caveat that the data is preliminary (if you want to share without including caveats, please check with Vipul Naik). We expect to have completed the first round of development by the end of July 2024. See the about page for more details. Also of interest: pageview data on analytics.vipulnaik.com, tutorial in README, request for feedback to EA Forum.
| Item | Value |
|---|---|
| Country | United States |
| Wikipedia page | https://en.wikipedia.org/wiki/Bill_%26_Melinda_Gates_Foundation |
| Best overview URL | https://en.wikipedia.org/wiki/Bill_%26_Melinda_Gates_Foundation |
| Facebook username | gatesfoundation |
| LinkedIn username | bill-&-melinda-gates-foundation |
| Website | https://www.gatesfoundation.org/ |
| Donations URL | https://www.gatesfoundation.org/How-We-Work/Quick-Links/Grants-Database |
| Twitter username | gatesfoundation |
| Page on philosophy informing donations | https://www.gatesfoundation.org/What-We-Do |
| Grant application process page | https://www.gatesfoundation.org/How-We-Work/General-Information/Grantseeker-FAQ |
| Regularity with which donor updates donations data | continuous updates |
| Regularity with which Donations List Website updates donations data (after donor update) | irregular |
| Lag with which donor updates donations data | months |
| Lag with which Donations List Website updates donations data (after donor update) | years |
| Data entry method on Donations List Website | SQL insertion commands generated by script https://github.com/riceissa/gates-foundation-iati-processing |
Brief history: The Gates Foundation launched in 2000, with precursors starting in the 1990s, financed by the personal wealth of co-founder Bill Gates from Microsoft. Starting 2005, it scaled up its giving significantly after a large funding commitment from Warren Buffett
Brief notes on broad donor philosophy and major focus areas: See https://www.gatesfoundation.org/Who-We-Are/General-Information/Foundation-Factsheet for the grantmaking areas. The four grantmaking areas are the Global Development Program, Global Health Program, Global Policy and Advocacy, and United States Program. Within the United States Program the focus is on K-12 education, the Internet, and emergency relief
Notes on grant publication logistics: Although the Gates Foundation has a grants database on its website, as well as individual grant pages for every grant, we use the IATI data instead, because it can be processed programmatically (the data on the site does not allow for full data download or easy programmatic processing). This leads to a few problems: first, IATI data does not include grants made in the United States, since it focuses on development assistance (DA) spending. Second, IATI data is updated more infrequently. Third, it may sometimes omit some information that is present in the grants database
Full donor page for donor Bill and Melinda Gates Foundation
We do not have any donee information for the donee University of California, San Diego in our system.
Full donee page for donee University of California, San Diego
| Item | Value |
|---|
| Cause area | Count | Median | Mean | Minimum | 10th percentile | 20th percentile | 30th percentile | 40th percentile | 50th percentile | 60th percentile | 70th percentile | 80th percentile | 90th percentile | Maximum |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Overall | 25 | 342,406 | 820,354 | 100,000 | 100,000 | 100,000 | 100,000 | 105,882 | 342,406 | 558,775 | 1,001,084 | 1,564,515 | 1,930,642 | 4,748,025 |
| Global health | 20 | 137,495 | 806,656 | 100,000 | 100,000 | 100,000 | 100,000 | 100,000 | 137,495 | 342,406 | 857,110 | 1,564,515 | 1,930,642 | 4,748,025 |
| Financing | 2 | 100,000 | 714,175 | 100,000 | 100,000 | 100,000 | 100,000 | 100,000 | 100,000 | 1,328,350 | 1,328,350 | 1,328,350 | 1,328,350 | 1,328,350 |
| Nutrition | 1 | 343,970 | 343,970 | 343,970 | 343,970 | 343,970 | 343,970 | 343,970 | 343,970 | 343,970 | 343,970 | 343,970 | 343,970 | 343,970 |
| Women's equality organisations and institutions | 2 | 1,001,084 | 1,301,705 | 1,001,084 | 1,001,084 | 1,001,084 | 1,001,084 | 1,001,084 | 1,001,084 | 1,602,326 | 1,602,326 | 1,602,326 | 1,602,326 | 1,602,326 |
If you hover over a cell for a given cause area and year, you will get a tooltip with the number of donees and the number of donations.
Note: Cause area classification used here may not match that used by donor for all cases.
| Cause area | Number of donations | Total | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Global health (filter this donor) | 20 | 16,133,112.00 | 105,882.00 | 2,294,121.00 | 7,379,180.00 | 558,775.00 | 1,930,642.00 | 100,000.00 | 3,264,512.00 | 100,000.00 | 100,000.00 | 300,000.00 |
| Women's equality organisations and institutions (filter this donor) | 2 | 2,603,410.00 | 0.00 | 1,001,084.00 | 1,602,326.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financing (filter this donor) | 2 | 1,428,350.00 | 0.00 | 1,328,350.00 | 0.00 | 100,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Nutrition (filter this donor) | 1 | 343,970.00 | 0.00 | 0.00 | 0.00 | 0.00 | 343,970.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total | 25 | 20,508,842.00 | 105,882.00 | 4,623,555.00 | 8,981,506.00 | 658,775.00 | 2,274,612.00 | 100,000.00 | 3,264,512.00 | 100,000.00 | 100,000.00 | 300,000.00 |
Graph of spending by cause area and year (incremental, not cumulative)
Graph of spending by cause area and year (cumulative)
There are no documents associated with this combination of donor and donee.
Graph of all donations (with known year of donation), showing the timeframe of donations
| Amount (current USD) | Amount rank (out of 25) | Donation date | Cause area | URL | Influencer | Notes |
|---|---|---|---|---|---|---|
| 105,882.00 | 16 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to help evaluate the utility of in vivo monoclonal antibody expression as a therapy for infectious diseases; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| 1,001,084.00 | 8 | Women's equality organisations and institutions | https://iatiregistry.org/publisher/bmgf | -- | to support the development of a Gender Analytics Cell toward generation of high quality analyses of NFHS-4 data on gender outcomes and norms to advance thinking and inform decision-makers at national and sub-national levels; Aid type: Project-type interventions. Affected countries: India. | |
| 342,406.00 | 13 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to help evaluate the utility of in vivo monoclonal antibody expression as a therapy for infectious diseases; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| 137,495.00 | 15 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to identify lead small molecules to treat the neglected tropical disease of schistosomiasis in developing countries; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| 1,328,350.00 | 7 | Financing/Formal sector financial intermediaries | https://iatiregistry.org/publisher/bmgf | -- | to catalyze the number of school-age children, in particular girls, attending secondary school by providing the rural poor with access to digital financial services for secure payment and recording of school fees.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| 100,000.00 | 17 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to help develop better drugs against the parasite Cryptosporidium, which is a major cause of diarrhea-associated infant deaths in developing countries, by using a genetically-modified yeast strain to identify the target of candidate compounds; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| 857,110.00 | 9 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to identify natural compounds in human milk that protect infants from environmental enteric disease and diarrhea; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| 857,110.00 | 9 | Global health/basic health care | https://iatiregistry.org/publisher/bmgf | -- | to identify natural compounds in human milk that protect infants from environmental enteric disease and diarrhea; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| 219,675.00 | 14 | Global health/basic health care | https://iatiregistry.org/publisher/bmgf | -- | to test three promising drug candidates for the potential to protect newborn babies against brain injury and cerebral palsy using a custom experimental model; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| 1,602,326.00 | 4 | Women's equality organisations and institutions | https://iatiregistry.org/publisher/bmgf | -- | to identify and address gaps in measurement of gender equity and empowerment, supporting best evidence measures for monitoring and evaluation of programs, policies and initiatives designed to improve gender equity and empowerment; Aid type: Project-type interventions. Affected countries: India. | |
| 4,748,025.00 | 1 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to accelerate the development of new effective antimalarial drugs through the identification of Plasmodium falciparum targets of novel scaffolds via a chemical genomic approach; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| 2,411,480.00 | 2 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to develop a point of care biometric device. Kidprint Phase II. Investment start date: 9/22/2016 to end date: 4/30/2019. Grantee name: University of California at San Diego; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| 558,775.00 | 11 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to develop a technology to quickly and accurately capture and classify fingerprints in rural settings and provide unique identification based on the biometric; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| 100,000.00 | 17 | Financing/Formal sector financial intermediaries | https://iatiregistry.org/publisher/bmgf | -- | to promote the use of mobile money in West Africa by enabling the low-cost transfer of money safely and directly from individuals to an institution like a school, along with the generation of receipts and transaction records; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| 1,930,642.00 | 3 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to accelerate the development of new effective antimalarial drugs through the identification of Plasmodium falciparum targets of novel scaffolds via a chemical genomic approach; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| 343,970.00 | 12 | Nutrition/basic nutrition | https://iatiregistry.org/publisher/bmgf | -- | to generate knowledge and public communication of learnings to move the child nutrition field forward; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| 100,000.00 | 17 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | To enable the design of effective combinations of next-generation anti-malarials for overcoming drug resistance by classifying anti-malarial drug candidates using a modified yeast strain displaying enhanced drug sensitivity.; Aid type: Project-type interventions. Affected regions: South of Sahara. | |
| 1,599,997.00 | 5 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to accelerate the development of new effective antimalarial drugs through the identification of Plasmodium falciparum targets of novel scaffolds via a chemical genomic approach; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| 100,000.00 | 17 | Global health/Reproductive health care | https://iatiregistry.org/publisher/bmgf | -- | to develop wireless tattoo-like electronics to continuously monitor vital signs of the pregnant mother and fetus.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| 1,564,515.00 | 6 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to develop a robust, reproducible set of assays that can be used to identify anti-malarial compounds that prevent the development of gametocytes or have transmission-blocking activities.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| 100,000.00 | 17 | Global health/basic health care | https://iatiregistry.org/publisher/bmgf | -- | to isolate and sequence RNA found in the hair and nails of newborns to uncover nutritional or environmental factors that cause newborn disease.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| 100,000.00 | 17 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to develop a novel delivery system for non-toxic, anti-roundworm proteins. Novel Delivery of Protein Anthelmintics. Investment start date: 11/1/2010 to end date: 4/30/2012. Grantee name: University of California at San Diego; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| 100,000.00 | 17 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to identify and validate new antigens for natural immune boosting TBV. GCE: Immune Boosting Malaria Transmission Blocking Vaccine (TBV). Investment start date: 11/1/2009 to end date: 6/30/2011. Grantee name: University of California at San Diego; Aid type: Project-type interventions. Affected regions: South of Sahara. | |
| 100,000.00 | 17 | Global health/malaria | https://iatiregistry.org/publisher/bmgf | -- | to create a humanized mouse in which P. falciparum/vivax complete the life cycle. GCE: Humanized Mouse: Recapitulate P. falciparum/vivax Cycle. Investment start date: 11/1/2009 to end date: 7/31/2011. Grantee name: University of California at San Diego; Aid type: Project-type interventions. Affected regions: South of Sahara. | |
| 100,000.00 | 17 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to develop and test engineered pseudoviruses called TIPs, which conditionally replicate along with the pathogen as it spreads, but have their virulence elements replaced with therapeutic elements that slow disease progression and transmission.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. |